Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive disorder caused by mutations in the TRIOBP gene, encoding TRIO and F-actin-binding protein. The condition is characterized by severe to profound sensorineural hearing loss.
Features include: Severe sensorineural hearing impairment.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Severe sensorineural hearing impairment |
TRIOBP function has not been fully characterized.
Autosomal recessive nonsyndromic hearing loss 28 is associated with mutations in the TRIOBP gene on chromosome 22.
Genetic testing for TRIOBP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive nonsyndromic hearing loss 28 has been reported in the published literature.
No clinical trials have been registered for autosomal recessive nonsyndromic hearing loss 28.
12 publications have been identified in PubMed for autosomal recessive nonsyndromic hearing loss 28. Research spans Review / Meta-Analysis (20%), Case Report / Case Series (20%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 2 | 20% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:55 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Patient case studies
2 |
20% |
Disease patterns and progression | 2 | 20% |
New treatment approaches | 2 | 20% |
Testing and diagnosis research | 1 | 10% |
Laboratory research | 1 | 10% |
Chan KH (2026). [PMID: 41623227](https://pubmed.ncbi.nlm.nih.gov/41623227/). *Laryngoscope*. [Epidemiology / Natural History]
Wu L (2026). [PMID: 41895920](https://pubmed.ncbi.nlm.nih.gov/41895920/). *J Mol Diagn*. [Gene Therapy / Novel Therapeutics]
Degiorgio D (2026). [PMID: 42240836](https://pubmed.ncbi.nlm.nih.gov/42240836/). *J Appl Lab Med*. [Case Report / Case Series]
Leoncio JC (2025). [PMID: 40801940](https://pubmed.ncbi.nlm.nih.gov/40801940/). *Hum Genet*. [Basic Science / Preclinical]
Elander J (2025). [PMID: 40685639](https://pubmed.ncbi.nlm.nih.gov/40685639/). *J Otolaryngol Head Neck Surg*. [Diagnostic / Biomarker]
Benamer N (2025). [PMID: 40506483](https://pubmed.ncbi.nlm.nih.gov/40506483/). *Commun Med (Lond)*. [Gene Therapy / Novel Therapeutics]
Rhim JW (2024). [PMID: 39296067](https://pubmed.ncbi.nlm.nih.gov/39296067/). *Heliyon*. [Case Report / Case Series]
Jang SH (2024). [PMID: 39609929](https://pubmed.ncbi.nlm.nih.gov/39609929/). *Genomics Inform*. [Review / Meta-Analysis]
Antunes LN (2024). [PMID: 39498320](https://pubmed.ncbi.nlm.nih.gov/39498320/). *Front Genet*. [Epidemiology / Natural History]
Jurca AD (2024). [PMID: 39064493](https://pubmed.ncbi.nlm.nih.gov/39064493/). *Medicina (Kaunas)*. [Review / Meta-Analysis]